XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $188,000 | -11.7% | 41,774 | -3.3% | 0.00% | – |
| Q4 2020 | $213,000 | -4.5% | 43,200 | +15.0% | 0.00% | – |
| Q3 2020 | $223,000 | +84.3% | 37,570 | -17.3% | 0.00% | – |
| Q2 2020 | $121,000 | +98.4% | 45,453 | +45.8% | 0.00% | – |
| Q1 2020 | $61,000 | -72.3% | 31,184 | 0.0% | 0.00% | – |
| Q4 2019 | $220,000 | -27.4% | 31,184 | +1.1% | 0.00% | -100.0% |
| Q3 2019 | $303,000 | -14.2% | 30,835 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $353,000 | +52.2% | 30,892 | +34.0% | 0.00% | – |
| Q1 2019 | $232,000 | – | 23,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|